Printer Friendly
The Free Library
14,581,301 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Blood substitutes topic

Subtopics (10)

 

Articles

1-62 out of 62 article(s)
Title Author Type Date Words
Cardiff scientist helps pioneer synthetic blood. Apr 16, 2009 340
Scientists to create 'synthetic blood' for infection-free emergency transfusions. Mar 23, 2009 351
Synthetic Blood International, Inc. Acquires Exclusive License to Use New VCU Intellectual Property. May 23, 2008 572
Synthetic Blood International, Inc. Provides Updates on Pending Matters. May 16, 2008 652
Synthetic Blood International, Inc. to Open New Research Office at Virginia BioTechnology Research Park. May 7, 2008 723
Blood-substitute review faults FDA. May 6, 2008 530
Oxycyte is on track as oxygen carrier, not as 'faux' blood. May 1, 2008 1679
Synthetic Blood International Comments on JAMA Article About Hemoglobin-Based Blood Substitutes. Apr 29, 2008 390
Synthetic Blood International, Inc. Announces Filing of Protocol for Phase II-b Oxycyte Clinical Trial. Apr 14, 2008 555
Synthetic Blood International, Inc. Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial. Apr 4, 2008 497
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy. Mar 31, 2008 637
Synthetic Blood International, Inc. Expands Board of Directors. Mar 28, 2008 702
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen. Mar 24, 2008 613
Oxycyte(R) Treatment for Traumatic Brain Injury Featured in Miami Herald Article. Mar 18, 2008 425
Office of Naval Research Provides $3.5 Million in New Grants for Clinical Research Involving Synthetic Blood International's Oxycyte(R). Mar 6, 2008 917
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte. Feb 26, 2008 602
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board. Medical condition overview Feb 8, 2008 673
Synthetic Blood Expands Scientific Advisory Board. Jan 7, 2008 1279
Synthetic Blood Announces Oxycyte Development Strategy. Dec 17, 2007 804
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury. Dec 11, 2007 610
Synthetic Blood Announces VCURES Receives $1.3 Million From U.S. Navy for Decompression Sickness Research with Oxycyte. Nov 28, 2007 602
Synthetic Blood Announces Major Restructuring. Nov 20, 2007 1227
Synthetic Blood International's Oxycyte Featured on PBS' WIRED Science. Oct 31, 2007 601
CEO INTERVIEW: ROBERT NICORA - SYNTHETIC BLOOD INTERNATIONAL, INC. (SYBD). Sep 24, 2007 90
Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint. Clinical report May 15, 2007 724
Blood substitute testing takes to the air: Medical Services Enterprise, UCSD still debating over approval for local trials. Webb, Marion Jun 7, 2004 960
Sangart starts phase II trial: closely held San Diego-based biopharmaceutical firm Sangart Inc. Webb, Marion Brief Article Apr 19, 2004 72
Blood substitute consent. Brief Article Apr 1, 2004 256
Unusual experimental blood substitute study launched last month in Denver. Mar 9, 2004 379
Local company's blood substitute scheduled to be tested in Sweden. (Biotech). Webb, Marion Brief Article May 19, 2003 111
Sangart patents blood substitute. Brief Article Aug 1, 2002 521
Blood substitute saves life of Jehovah's Witness; FDA approval sought. Brief Article Jun 14, 2002 565
New blood substitute. (Briefly). Brief Article Dec 1, 2001 126
MEDICAL PROGRESS. Brief Article Aug 1, 2001 261
Blood Relatives. WANG, LINDA Mar 31, 2001 2052
Artificial Blood Tests Good Sign for European Approvals. Webb, Marion Brief Article Sep 18, 2000 322
Partners Make Another Attempt at Creating Blood Substitute. WEBB, MARION Brief Article Aug 14, 2000 968
FAKE BLOOD Ready to Flow. Cannell, Michael Mar 8, 1999 1478
FDA asks Northfield Labs to expand number of patients in Phase III trials of blood substitute, PolyHeme Article Aug 31, 1998 170
Synthetic Blood International Transfers Perfluorocarbon Development to Southern California. Aug 12, 1998 247
Synthetic Blood International Announces Product Development, Marketing Agreement. Article Aug 6, 1998 307
Sanguine Contract With Battelle Completed and Funding in Place for the Development of Blood Substitute. Article Jun 18, 1998 186
Sanguine Contract With Battelle Completed and Funding in Place for the Development of Blood Substitute. Jun 18, 1998 186
Sangui BioTech Inc. announces definitive agreement to acquire controlling shares from Citadel Investment Systems Inc. of Colorado. Mar 19, 1997 390
BioTime to Raise $3,000,000 to $6,000,000 in Rights Offering. Dec 5, 1996 475
BioTime begins Phase III clinical trials of Hextend. Oct 31, 1996 109
BioTime's Hextend cleared for Phase III clinical trials. Aug 19, 1996 251
XOMA'S Neuprex Product Clears First Interim Safety Analyses in Two Phase II Trial Indications. Jul 31, 1996 757
Alliance Pharmaceutical Corp. announces public offering. Apr 2, 1996 181
Synthetic Blood International Inc. announces completion of agreement for $12 million financing. Mar 21, 1996 241
Blood substitute offers advantages. Brief Article Feb 1, 1996 453
Enzon reports first quarter results and records a 37% sales increase. Nov 14, 1995 593
Alliance Pharmaceutical Corp. announces first-quarter financial results. Nov 13, 1995 438
Synthetic Blood International, Inc., Announces Secondary Public Offering. Oct 23, 1995 203
Synthetic Blood International Inc. announces completion of agreement for $10 million financing. Oct 3, 1995 370
ENZON REPORTS FISCAL YEAR RESULTS; And Records a 35% Sales Increase and a 31% Decrease in Recurring Expenses. Sep 11, 1995 1124
Corporate Profile for Synthetic Blood International Inc., dated June 16. Company Profile Jun 16, 1995 369
Synthetic Blood International Inc. releases clinical trial schedule for three products. Jun 9, 1995 243
ENZON REPORTS PROGRESS ON BLOOD SUBSTITUTE PROGRAM; And Engages Financial Advisor. May 3, 1995 392
Nation's blood supply safer than ever. Feb 1, 1995 572
Improving humans' blood with crocodiles'. Adler, Tina Brief Article Jan 21, 1995 343
ENZON ANNOUNCES FIRST QUARTER RESULTS; And Reports a Net Loss of $0.07 vs. $0.26. Nov 14, 1994 706

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles